Based on cerebrovascular reactivity, to explore the mechanism of zhu's scalp needle for the treatment of motor function injury in patients with acute ischemic stroke

acute ischemic stroke

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006594

Enrollment

Unknown

Registered

2022-09-13

Start date

2022-09-13

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

zhu's scalp needle treatment group: zhu's scalp needle

control group:head needle

Eligibility

Sex/Gender

All

Age

35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Consistent with the diagnosis of acute ischemic stroke in Western medicine; (2) Patients within 1 week of onset; (3) persons aged 35-75; (4) FuGL-Meyer scale score =99; (5) Patients with first stroke or recurrent stroke had completely returned to normal before the onset of the disease, that is, mRS score =1; (6) Informed consent has been signed by the patient himself or his legal representative before the clinical study begins;

Exclusion criteria

Exclusion criteria: (1) Intracranial hemorrhage diseases observed by head CT: patients with cerebral hemorrhage and subarachnoid hemorrhage; (2) Severe disturbance of consciousness: patients with NIHSS item score of 1a consciousness level > 1; (3) Transient cerebral ischemia; (4) Patients with cerebral hernia after admission; (5) Aphasia patients with stroke; (6) Patients with cognitive impairment: MMSE score: illiteracy =17, primary school =20, middle school and above =24; (7) patients with severe hypertension (systolic blood pressure =200mmHg, diastolic blood pressure =110mmHg), diabetes (fasting blood glucose =10mmol/L after hypoglycemic drug treatment) and other diseases, which are still not controlled after treatment; (8) patients with claudication, osteoarthritis, rheumatoid arthritis, gout arthritis and other diseases affecting limb activities; (9) Lack of clear imaging diagnostic evidence such as CT and MRI, or imaging diagnostic evidence is insufficient to confirm the diagnosis; (10) Excluding patients with brain lesions caused by brain trauma, poisoning, post-epileptic state, tumor stroke, encephalitis and serious dysfunction of vital organs; (11) those who do not cooperate with treatment;

Design outcomes

Primary

Measure	Time frame
Vm;	—

Secondary

Measure	Time frame
Cranial nerve function score;	—

Countries

china

Contacts

Public ContactLei Xulu

Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine

lxl2524@126.com13260205482

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026